Persistence with bisphosphonate treatment and fracture risk in a managed care setting

被引：0
|
作者：
Cosman, F
Gold, DT
Frytak, J
Baran, RW
Amonkar, MM
Martin, B
机构：
[1] Helen Hayes Hosp, W Haverstraw, NY USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] i3 Magnifi, Eden Prairie, MN USA
[4] Roche Biomed Labs, Nutley, NJ USA
[5] GSK, Collegeville, PA USA
[6] Univ Arkansas, Little Rock, AR 72204 USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2005年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [21] BISPHOSPHONATE TREATMENT AND MORTALITY RISK REDUCTION AFTER OSTEOPOROTIC HIP FRACTURE
    Diehl, Maria
    Beratarrechea, Andrea
    Pace, Natalia
    Saimovici, Javier
    Trossero, Adriana
    Perman, Gaston
    Plantalech, Luisa
    ACTUALIZACIONES EN OSTEOLOGIA, 2013, 9 (02) : 154 - 164
  • [22] Hemophilia in the Managed Care Setting
    Dalton, Dan R.
    AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (06): : S123 - S130
  • [23] LIABILITY IN THE MANAGED CARE SETTING
    GNESSIN, AM
    SETTING THE STAGE : HMOS AND THE AMERICAN HEALTH SYSTEM IN THE NEXT DECADE, 1989, : 115 - &
  • [24] Is Atypical Bisphosphonate Treatment Response a Risk Factor for Atypical Femoral Fracture?
    Troy, Karen L.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2017, 99 (19):
  • [25] THE PSYCHOTHERAPIST AND THE MANAGED CARE SETTING
    AUSTAD, CS
    SHERMAN, WO
    MORGAN, T
    HOLSTEIN, L
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 1992, 23 (04) : 329 - 332
  • [26] Identification of untreated women at risk for osteoporosis in a managed care setting.
    Rolnick, SJ
    Kopher, R
    Abbott, T
    Jackson, J
    Fischer, LR
    Compo, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S251 - S251
  • [27] Persistence to bisphosphonate treatment in actual clinical practice
    Van Staa, TP
    Geusens, P
    Leufkens, HGM
    Cooper, C
    BONE, 2005, 36 : S412 - S412
  • [28] BARRIERS TO PHARMACEUTICAL CARE IN THE MANAGED CARE SETTING
    LOUIE, N
    ROBERTSON, N
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (08): : 1614 - 1617
  • [29] The effect of screening versus nonscreening on treatment authorization in a managed care setting
    Howard, RC
    Bassos, CA
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2000, 31 (05) : 526 - 530
  • [30] Managed care risk contracts and substance abuse treatment
    Sturm, R
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2000, 37 (02) : 219 - 225
12345